Hoth Therapeutics (HOTH) Competitors $1.22 +0.01 (+0.83%) Closing price 02/4/2025 04:00 PM EasternExtended Trading$1.22 0.00 (-0.41%) As of 02/4/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HOTH vs. SNYR, CVM, VRCA, RNXT, COEP, BIVI, CGTX, XCUR, XLO, and LEXXShould you be buying Hoth Therapeutics stock or one of its competitors? The main competitors of Hoth Therapeutics include Synergy CHC Corp. (Uplisting) (SNYR), CEL-SCI (CVM), Verrica Pharmaceuticals (VRCA), RenovoRx (RNXT), Coeptis Therapeutics (COEP), BioVie (BIVI), Cognition Therapeutics (CGTX), Exicure (XCUR), Xilio Therapeutics (XLO), and Lexaria Bioscience (LEXX). These companies are all part of the "pharmaceutical products" industry. Hoth Therapeutics vs. Synergy CHC Corp. (Uplisting) CEL-SCI Verrica Pharmaceuticals RenovoRx Coeptis Therapeutics BioVie Cognition Therapeutics Exicure Xilio Therapeutics Lexaria Bioscience Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) and Hoth Therapeutics (NASDAQ:HOTH) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation, risk and community ranking. Does the MarketBeat Community prefer SNYR or HOTH? Hoth Therapeutics received 71 more outperform votes than Synergy CHC Corp. (Uplisting) when rated by MarketBeat users. However, 100.00% of users gave Synergy CHC Corp. (Uplisting) an outperform vote while only 65.77% of users gave Hoth Therapeutics an outperform vote. CompanyUnderperformOutperformSynergy CHC Corp. (Uplisting)Outperform Votes2100.00% Underperform VotesNo VotesHoth TherapeuticsOutperform Votes7365.77% Underperform Votes3834.23% Which has stronger earnings & valuation, SNYR or HOTH? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynergy CHC Corp. (Uplisting)N/AN/AN/AN/AN/AHoth TherapeuticsN/AN/A-$7.84M-$1.32-0.92 Do analysts prefer SNYR or HOTH? Synergy CHC Corp. (Uplisting) presently has a consensus price target of $10.00, suggesting a potential upside of 136.97%. Hoth Therapeutics has a consensus price target of $4.00, suggesting a potential upside of 227.87%. Given Hoth Therapeutics' higher probable upside, analysts clearly believe Hoth Therapeutics is more favorable than Synergy CHC Corp. (Uplisting).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC Corp. (Uplisting) 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Hoth Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Does the media prefer SNYR or HOTH? In the previous week, Synergy CHC Corp. (Uplisting) had 1 more articles in the media than Hoth Therapeutics. MarketBeat recorded 1 mentions for Synergy CHC Corp. (Uplisting) and 0 mentions for Hoth Therapeutics. Synergy CHC Corp. (Uplisting)'s average media sentiment score of -1.00 equaled Hoth Therapeutics'average media sentiment score. Company Overall Sentiment Synergy CHC Corp. (Uplisting) Negative Hoth Therapeutics Negative Is SNYR or HOTH more profitable? Synergy CHC Corp. (Uplisting)'s return on equity of 0.00% beat Hoth Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Synergy CHC Corp. (Uplisting)N/A N/A N/A Hoth Therapeutics N/A -89.68%-82.61% Do insiders & institutionals believe in SNYR or HOTH? 7.1% of Hoth Therapeutics shares are owned by institutional investors. 10.6% of Hoth Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummarySynergy CHC Corp. (Uplisting) and Hoth Therapeutics tied by winning 5 of the 10 factors compared between the two stocks. Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOTH vs. The Competition Export to ExcelMetricHoth TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.42M$6.87B$5.66B$9.11BDividend YieldN/A2.88%5.28%4.00%P/E Ratio-0.9210.0588.3918.31Price / SalesN/A320.111,075.2481.15Price / CashN/A22.6637.4433.55Price / Book0.605.305.124.76Net Income-$7.84M$125.74M$108.98M$223.10M7 Day Performance-1.61%1.48%0.49%0.18%1 Month Performance57.42%-4.86%-0.88%-1.98%1 Year Performance-9.63%12.48%26.71%23.41% Hoth Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOTHHoth Therapeutics2.571 of 5 stars$1.22+0.8%$4.00+227.9%-5.4%$8.42MN/A-0.924Negative NewsSNYRSynergy CHC Corp. (Uplisting)N/A$3.80+2.2%$10.00+163.2%N/A$33.06MN/A0.0040Gap UpCVMCEL-SCIN/A$0.44+6.2%N/A-86.4%$32.31MN/A-0.8543Gap UpVRCAVerrica Pharmaceuticals4.5817 of 5 stars$0.71-1.6%$9.50+1,236.1%-88.2%$32.19M$5.12M-0.3940Positive NewsRNXTRenovoRx1.7167 of 5 stars$1.33-3.6%$6.50+388.7%-20.6%$31.92MN/A-2.336Gap UpCOEPCoeptis Therapeutics1.1826 of 5 stars$13.05+9.6%N/A+7.9%$31.72MN/A-2.282BIVIBioVie1.3988 of 5 stars$1.78-8.0%$3.00+69.0%+62.6%$31.36MN/A-0.1510Upcoming EarningsCGTXCognition Therapeutics3.8683 of 5 stars$0.75-0.9%$8.30+1,011.1%-72.6%$31.04MN/A-0.7720Gap DownXCURExicure1.339 of 5 stars$11.82-1.7%N/A+1,892.6%$30.79M$500,000.00-5.7150XLOXilio Therapeutics3.7872 of 5 stars$0.71-13.7%$4.00+465.0%-0.6%$30.38M$4.62M-0.4070LEXXLexaria Bioscience3.5174 of 5 stars$1.73-0.9%$9.50+450.7%+1.7%$30.27M$460,000.00-3.457 Related Companies and Tools Related Companies Synergy CHC Corp. (Uplisting) Alternatives CEL-SCI Alternatives Verrica Pharmaceuticals Alternatives RenovoRx Alternatives Coeptis Therapeutics Alternatives BioVie Alternatives Cognition Therapeutics Alternatives Exicure Alternatives Xilio Therapeutics Alternatives Lexaria Bioscience Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HOTH) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hoth Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HOTH Stock Alerts